340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

CMS Gives Drugmakers Extension to Report 5i AMP Per Final Rule

July 1 is the new deadline
 

Print Article

April 6, 2016—The Centers for Medicare & Medicaid Services is giving drug manufacturers a three-month extension to begin calculating and reporting, in accordance with new federal regulations, the average manufacturer price for “5i” inhalation, infusion, instilled, implanted or injectable drugs that are not generally dispensed through retail community pharmacies. [ms-protect-content id=”2799″]

CMS announced the delay, from April 1 to July 1, in a March 31 communication to drug manufacturers. The agency explained that “it has come to our attention that drug manufacturers may need additional time to complete system modifications” to calculate and report AMP for 5i drugs consistent with CMS’s covered outpatient drug final rule, aka the final AMP rule. Between now and July 1, manufacturers are still required to report monthly and quarterly 5i AMPs consistent with the final AMP rule, but may do so using reasonable assumptions, CMS said.

The 340B ceiling price is statutorily defined as AMP reduced by the Medicaid rebate percentage, commonly referred to as the unit rebate amount. [/ms-protect-content]

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
5h

Drugmakers continue suspending #340B contract pharmacy restrictions in a growing number of states that prohibit conditions on access to discounted pricing. State lawmakers on both sides of the political aisle recognize the need to #Protect340B.

Reply on Twitter 1959982744215388575 Retweet on Twitter 1959982744215388575 Like on Twitter 1959982744215388575 Twitter 1959982744215388575
340bhealth 340B Health @340bhealth ·
23 Aug

We stand with safety-net providers to #Protect340B in legislatures and in the courts. #Becauseof340B, tens of millions of uninsured and underinsured patients have better access to care they need, supporting healthy families and thriving communities.

Reply on Twitter 1959351057563148625 Retweet on Twitter 1959351057563148625 Like on Twitter 1959351057563148625 Twitter 1959351057563148625
340bhealth 340B Health @340bhealth ·
22 Aug

#Becauseof340B, our hospitals can provide patients financial assistance, hire more clinical pharmacists, keep their doors open, and so much more. Learn more about where these savings go and why we must #Protect340B: http://becauseof340b.org/.

Reply on Twitter 1958923115905646845 Retweet on Twitter 1958923115905646845 Like on Twitter 1958923115905646845 1 Twitter 1958923115905646845
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health